DeepMed Research

ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Daily vs Alternate Day Iron Supplementation for Pregnant Women With Iron Deficiency Anemia

Not Applicable

Completed

Conditions: Iron Deficiency Anemia

Interventions: Dietary Supplement: Ferrous Sulfate

First Posted Date: 2018-06-19

Last Posted Date: 2020-03-18

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 88

Registration Number: NCT03562143

Locations: 🇺🇸
Mount Sinai West, New York, New York, United States

Thromboelastometry Prediction Utility for Risk of Abortion

Completed

Conditions: Pregnancy Trimester, First
Abortion, Threatened

Interventions: Diagnostic Test: Thromboelastometry testing

First Posted Date: 2018-06-07

Last Posted Date: 2020-06-01

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 98

Registration Number: NCT03548701

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

Effect of Music Therapy on Infants with Neonatal Abstinence Syndrome

Not Applicable

Recruiting

Conditions: NAS

Interventions: Other: Tonal Vocal holding
Other: Gato box
Other: Ocean disc
Other: Muted shaker
Other: Contingent singing
Behavioral: Song of Kin

First Posted Date: 2018-05-23

Last Posted Date: 2025-02-24

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 200

Registration Number: NCT03533985

Locations: 🇺🇸
Tulane University Hospital, New Orleans, Louisiana, United States
🇺🇸
Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, United States
🇺🇸
Northwell Health, New Hyde Park, New York, United States

and more 3 locations

Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)

Phase 4

Completed

Conditions: Central Centrifugal Cicatricial Alopecia

Interventions: Drug: Apremilast

First Posted Date: 2018-05-11

Last Posted Date: 2022-05-09

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 20

Registration Number: NCT03521687

Locations: 🇺🇸
Mount Sinai West Dermatology, New York, New York, United States

Response to Anti-hypertensives in Pregnant and Postpartum Patients

Phase 4

Completed

Conditions: Hypertension in Pregnancy
Preeclampsia

Interventions: Drug: Nifedipine
Drug: Labetalol

First Posted Date: 2018-04-24

Last Posted Date: 2021-05-24

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 109

Registration Number: NCT03506724

Locations: 🇺🇸
Maimonides Hospital, Brooklyn, New York, United States
🇺🇸
Mount Sinai West, New York, New York, United States

Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color

Phase 4

Completed

Conditions: Psoriasis
Plaque Psoriasis

Interventions: Drug: Vehicle foam
Drug: Enstilar® foam

First Posted Date: 2018-04-24

Last Posted Date: 2021-01-20

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 25

Registration Number: NCT03506477

Locations: 🇺🇸
Mount Sinai West, New York, New York, United States

Investigating the Effect of Acupressure on Shivering During a Cesarean Delivery in Women Who Were Previously Laboring With an Epidural

Not Applicable

Terminated

Conditions: Cesarean Delivery
Shivering
Labor

Interventions: Device: Sham bracelet
Device: Acupressure bracelet

First Posted Date: 2018-04-13

Last Posted Date: 2022-10-14

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 43

Registration Number: NCT03497507

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Whether Proton Pump Inhibitors, Administered Prior to or After Surgery, Can Reduce the Incidence and/or Severity of Difficulty Swallowing Foods and/or Liquids,Following Anterior Cervical Surgery

Phase 2

Withdrawn

Conditions: Degenerative Joint Disease
Dysphagia
GERD

Interventions: Drug: Placebo Oral Tablet
Drug: Esomeprazole

First Posted Date: 2018-04-04

Last Posted Date: 2020-11-23

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Registration Number: NCT03488147

Locations: 🇺🇸
Mount Sinai West, New York, New York, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).

Phase 4

Completed

Conditions: Cardiovascular Diseases

Interventions: Drug: Placebos
Drug: Empagliflozin

First Posted Date: 2018-04-02

Last Posted Date: 2021-03-25

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 84

Registration Number: NCT03485222

Locations: 🇺🇸
Mount Sinai Heart - Icahn School of Medicine at Mount Sinai, New York, New York, United States

Online Emotion Regulation Group Intervention

Not Applicable

Completed

Conditions: Traumatic Brain Injury
Emotion Dysfunction
Emotion Dysregulation
Executive Dysfunction

Interventions: Behavioral: Online Emotion Regulation Skills-training

First Posted Date: 2018-03-27

Last Posted Date: 2022-10-06

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 137

Registration Number: NCT03479606

Locations: 🇺🇸
The Brain Injury Research Center at Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy